WO2003025168A1 - Nouvelle proteine et adn associe - Google Patents

Nouvelle proteine et adn associe Download PDF

Info

Publication number
WO2003025168A1
WO2003025168A1 PCT/JP2002/009444 JP0209444W WO03025168A1 WO 2003025168 A1 WO2003025168 A1 WO 2003025168A1 JP 0209444 W JP0209444 W JP 0209444W WO 03025168 A1 WO03025168 A1 WO 03025168A1
Authority
WO
WIPO (PCT)
Prior art keywords
diseases
protein
activity
dna
inhibiting
Prior art date
Application number
PCT/JP2002/009444
Other languages
English (en)
French (fr)
Inventor
Atsushi Nakanishi
Yumiko Uno
Yoji Sagiya
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Priority to US10/490,080 priority Critical patent/US20040253597A1/en
Priority to EP02798663A priority patent/EP1428877A4/en
Publication of WO2003025168A1 publication Critical patent/WO2003025168A1/ja

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
PCT/JP2002/009444 2001-09-17 2002-09-13 Nouvelle proteine et adn associe WO2003025168A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/490,080 US20040253597A1 (en) 2001-09-17 2002-09-13 Novel protein and dna thereof
EP02798663A EP1428877A4 (en) 2001-09-17 2002-09-13 NEW PROTEIN AND ASSOCIATED DNA

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2001/281992 2001-09-17
JP2001281992 2001-09-17
JP2001306873 2001-10-02
JP2001/306873 2001-10-02
JP2002113279 2002-04-16
JP2002/113279 2002-04-16

Publications (1)

Publication Number Publication Date
WO2003025168A1 true WO2003025168A1 (fr) 2003-03-27

Family

ID=27347519

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/009444 WO2003025168A1 (fr) 2001-09-17 2002-09-13 Nouvelle proteine et adn associe

Country Status (3)

Country Link
US (1) US20040253597A1 (ja)
EP (1) EP1428877A4 (ja)
WO (1) WO2003025168A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816139A1 (en) * 2002-11-22 2007-08-08 Medical College Of Georgia Research Institute, Inc. Nact as a target for lifespan expansion and weight reduction
EP1572730A4 (en) * 2002-11-22 2006-04-19 Med College Georgia Res Inst NACT USED AS TARGET FOR EXTENDING LIFETIME AND WEIGHT REDUCTION

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002012340A2 (en) * 2000-08-03 2002-02-14 Incyte Genomics, Inc. Transporters and ion channels
WO2002018412A1 (en) * 2000-08-28 2002-03-07 Human Genome Sciences, Inc. 17 human secreted proteins
WO2002046407A2 (en) * 2000-12-05 2002-06-13 Pe Corporation (Ny) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002255478A1 (en) * 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
WO2002072757A2 (en) * 2001-03-08 2002-09-19 Curagen Corporation Novel proteins and nucleic acids encoding same
US20020193582A1 (en) * 2001-06-18 2002-12-19 Millennium Pharmaceuticals, Inc. 69624, a novel human transporter family member and uses therefor
JP2005503790A (ja) * 2001-08-17 2005-02-10 インサイト・ゲノミックス・インコーポレイテッド 輸送体及びイオンチャネル

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002012340A2 (en) * 2000-08-03 2002-02-14 Incyte Genomics, Inc. Transporters and ion channels
WO2002018412A1 (en) * 2000-08-28 2002-03-07 Human Genome Sciences, Inc. 17 human secreted proteins
WO2002046407A2 (en) * 2000-12-05 2002-06-13 Pe Corporation (Ny) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
PAJOR A.M. ET AL.: "Molecular cloning and functional expression of a sodium-dicarboxylate cotransporter from human kidney", AM. J. PHYSIOL., vol. 270, no. 4, 1996, pages F642 - F648, XP002961004 *
PAJOR A.M. ET AL.: "Molecular cloning, chromosomal organization and functional characterization of a sodium-dicarboxylate cotransporter from mouse kidney", AM. J. PHYSIOL. RENAL. PHYSIOL., vol. 279, 2000, pages F482 - F490, XP002966804 *
See also references of EP1428877A4 *
SEKINE T. ET AL.: "Cloning, functional characterization and localization of a rat renal na+-dicarboxylate transporter", AM. J. PHYSIOL., vol. 275, no. 4, 1998, pages F298 - F305, XP002966805 *

Also Published As

Publication number Publication date
EP1428877A1 (en) 2004-06-16
US20040253597A1 (en) 2004-12-16
EP1428877A4 (en) 2004-11-17

Similar Documents

Publication Publication Date Title
WO2003059251A3 (en) Antibody targeting compounds
BR0316886A (pt) Composição, processo para a preparação de uma composição, produto para contraste, usos de uma composição e uso de partìculas magnéticas
WO2005062977A3 (en) Prostate cancer specific internalizing human antibodies
WO2005003296A3 (en) Albumin fusion proteins
WO2002100860A3 (fr) Composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
WO2004113498A3 (en) Rna interferases and methods of use thereof
WO2004080418A3 (en) Nucleic acid compounds for inhibiting angiogenesis and tumor growth
EP1440981A3 (en) Full-length human cdna
WO2001047959A3 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
WO2003046200A3 (en) Methods for ligand discovery
WO2003030821A3 (en) Albumin fusion proteins
WO2005025615A3 (en) FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY
DE60205820D1 (de) Verfahren zur Herstellung von Anionenaustauschharzen
WO2003078574A3 (en) Novel metabolic targets and markers
WO2004100891A3 (en) Cytotoxic indeno and isoindoloisoquinolones
WO2003025168A1 (fr) Nouvelle proteine et adn associe
DE60239286D1 (de) Verfahren zur herstellung von trans-1,4-cyclohexandicarbonsäure
WO1999046374A3 (de) Menschliche nukleinsäuresequenzen aus prostatatumorgewebe
WO1999002704A3 (en) Dual specifically phosphatase and methods of use
WO2002079122A3 (en) Methods of synthesizing phenol-containing compounds
WO2005019475A3 (en) Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
WO2003049696A3 (en) Glucosamine organic acid adducts
WO1999031253A3 (en) Novel flea epoxide hydrolase nucleic acid molecules, proteins and uses thereof
WO2002062944A2 (fr) Nouveau peptide physiologiquement actif et son utilisation
WO2003037257A3 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002798663

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10490080

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2002798663

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002798663

Country of ref document: EP